3rd Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$520,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax policy; LIFO-last-in, first-out; foreign earnings, corporate tax rate.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
DAMON SHELBY PORTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Tariff (miscellaneous tariff bills) TAR

USTR section 301 proposed tariffs

LobbyistCovered position, as disclosed
JOSHUA C BABB —
DAMON SHELBY PORTER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

The Social Determinants Accelerator Act, S.4264; U.S. MADE Act of 2020, H.R. 6880; MADE in America Act, H.R.3; Oncology Care Model; Radiation Oncology APM; Lower Drug Costs Now Act of 2019, H.R.1845; ALERT Act of 2019; Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R.748; CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution. H.R.2503 - The Social Determinants Accelerator Act of 2021, H.R.3 - Drug pricing and transparency, H.R.3, H.R.19; Budget Reconciliation; International price referencing, H.R.19; Medical Supplies for Pandemics Act of 2021, S.65; Improving Seniors Timely Access to Care Act, H.R. 3173; Safe Step Act, 2163; Buy America and domestic sourcing, strategic national stockpile H.R.3635; S.308; H.R.2780; Supply chain, global operations, trade; Opioids, substance abuse and prescription safety alert systems; Issues remain the same with addition of Build Back Better Act, H.R.5376.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
DAMON SHELBY PORTER —
PETER SLONE —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 5376 (117th), H.R. 3 (117th), S. 308 (117th), H.R. 748 (117th), H.R. 3635 (117th), S. 4264 (117th), H.R. 6800 (117th), H.R. 2503 (117th), H.R. 1845 (117th), S. 65 (117th), H.R. 2780 (117th), H.R. 19 (117th), H.R. 6880 (117th), H.R. 3173 (117th)

Medicare/Medicaid MMM

Issues related to physician reimbursement for Part B drugs; Support for increased transparency and accountability in Medicare's local determination process (S.794/H.R. 3635); Issues as they relate to opioid abuse policy; General Medicare/Medicaid Issues; Issues related to reimbursement for radiation therapy services; 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices; Pandemic and All Hazards Preparedness Act reauthorization; issues related to step therapy policies in Medicare Advantage plans; Medicare physician payment; Issues related to an alternative payment model for radiation oncology services; Issues related to the Center for Medicare and Medicaid Innovation; Issues related to the ANPRM International Pricing Index Model for Medicare Part B Drugs; issues related to the Oncology Care First model, H.R. 4621, the Collecting and Analyzing Resources Integral and Necessary for Guidance (CARING) for Social Determinants Act of 2019, S. 2986/H.R. 4004, the Social Determinants Accelerator Act. Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748- CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution; H.R. 1868, Sequestration; Social determinants of health; health disparities in underserved communities, chronic health conditions, H.R.2503;

LobbyistCovered position, as disclosed
JOSHUA C BABB —
THOMAS BORCK —
BEN JONES —
LISA LANGENDERFER —
DAMON SHELBY PORTER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4004 (117th), S. 794 (117th), H.R. 2503 (117th), S. 2986 (117th), H.R. 4621 (117th), H.R. 1868 (117th), H.R. 3635 (117th), H.R. 748 (117th), H.R. 6800 (117th)

Pharmacy PHA

Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion; support for legislation to preserve patient access to oral oncolytic dispensed by community-based cancer clinics (H.R. 1316); DIR (H.R. 1038), advocacy related to ending retroactive direct and indirect remuneration fees levied on pharmacists; Provider status (H.R. 592), advocacy related to recognizing and reimbursing pharmacists for providing appropriate medical services; H.R. 6688, The Analyzing and Leveraging Existing Rx Transactions (ALERT) Act. H.R. 6880 - The Buy American Medical Supplies Act, Lower Drug Costs Now Act of 2019. Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800, Heroes Act, and COVID-19 vaccine distribution; Pharmacy provider status, retail pharmacy. H.R.2759, S.1362.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
THOMAS BORCK —
BEN JONES —
LISA LANGENDERFER —
DAMON SHELBY PORTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (117th), H.R. 2759 (117th), H.R. 1316 (117th), H.R. 6688 (117th), H.R. 6880 (117th), H.R. 592 (117th), S. 1362 (117th), H.R. 1038 (117th), H.R. 6800 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.